MDM2 inhibition in liposarcoma: a step in the right direction

Lancet Oncol. 2012 Nov;13(11):1070-1. doi: 10.1016/S1470-2045(12)70457-6. Epub 2012 Oct 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Female
  • Humans
  • Liposarcoma / drug therapy*
  • Male
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*
  • Tumor Suppressor Protein p53*

Substances

  • Antineoplastic Agents
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2